Efficacy and safety of hyperthermic intraperitoneal chemotherapy in treatment of primary or recurrent ovarian cancer: systematic review and meta-analysis - Scorecard - MDSpire
Advertisement
Efficacy and safety of hyperthermic intraperitoneal chemotherapy in treatment of primary or recurrent ovarian cancer: systematic review and meta-analysis
Clinical Scorecard: Effectiveness and Safety of Hyperthermic Intraperitoneal Chemotherapy for Primary and Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Epithelial Ovarian Cancer (EOC)
Key Mechanisms
HIPEC enhances drug efficacy and tissue penetration through intra-abdominal chemotherapy administered intraoperatively after heating chemotherapeutic agents.
Target Population
Patients with primary advanced or recurrent EOC.
Care Setting
Oncology, specifically during cytoreductive surgery.
Key Highlights
HIPEC may provide a survival benefit in selected patients with primary advanced ovarian cancer.
HIPEC after neoadjuvant chemotherapy and interval debulking was associated with improved overall survival in primary ovarian cancer.
HIPEC has no established role in recurrent ovarian cancer.
HIPEC is a potential safe treatment option for ovarian cancer.
Guideline-Based Recommendations
Diagnosis
Diagnosis of EOC should consider FIGO staging and histological assessment.
Management
Standard treatment includes primary debulking surgery followed by systemic chemotherapy, with HIPEC as an adjunct in selected cases.
Monitoring & Follow-up
Monitor for postoperative complications and assess overall survival and progression-related outcomes.
Risks
Potential postoperative complications associated with HIPEC should be evaluated.
Patient & Prescribing Data
Patients with primary advanced or recurrent EOC undergoing cytoreductive surgery.
HIPEC may improve overall survival in primary settings but lacks evidence of benefit in recurrent cases.
Clinical Best Practices
Consider HIPEC for selected patients with primary advanced EOC during interval debulking surgery.
Evaluate the risks and benefits of HIPEC in the context of individual patient scenarios.
